Project Grant R01AI185849

Award Date 6/11/24
Completion Date 4/30/29
Dollars Obligated $1.9M
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $530,385.00 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to study how host acetylation factors regulate the activity of the flavivirus NS3 protein, which is essential for viral replication. The research aims to elucidate the molecular mechanisms by which acetylation of NS3 by...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $218,900 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Alabama at Birmingham (UAB) to investigate the molecular determinants that influence flavivirus protease cleavage and how these factors affect viral fitness. The project aims to elucidate the proteolytic mechanisms used by flaviviruses, such as Dengue, Zika, West Nile, and Yellow Fever viruses, to...
The Flavivirus and Alphavirus REVAMPP (FLARE) Center, funded by a $46,715,173 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), is developing and optimizing protein nanoparticle, virion-based, and mRNA vaccine platforms, as well as monoclonal antibody-based treatments to rapidly respond to emerging flaviviruses and alphaviruses with pandemic potential. The Center integrates the work of multiple...
This Project Grant award of $449,625 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to develop a novel mouse model that co-engrafts a functional human immune system and human skin organoids. The goal is to create a platform that accurately mimics human cutaneous responses to arthropod-borne virus (ABV) transmission, which is critical for understanding transmission mechanisms and developing...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $387,783 to The Pennsylvania State University (Penn State) for a 5-year research project focused on understanding the dynamics of how pathogenic human viruses, such as enveloped RNA viruses (e.g., Dengue, Zika), non-enveloped RNA viruses (e.g., Coxsackie viruses), and non-enveloped DNA viruses (e.g., Human...
This $769,115 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to advance the understanding of how neurotropic viruses, including flaviviruses and alphaviruses, can directly enter the central nervous system (CNS) through newly described meningeal structures called arachnoid cuff exit (ACE) points. The research team from The Washington University in St. Louis will...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $506,530 to Albert Einstein College of Medicine and the University of Colorado-Denver to conduct research on the role of cell-to-cell transmission in alphavirus infection and disease. The key objectives are to: Determine the mechanisms by which antibodies block cell-to-cell spread of alphaviruses like chikungunya and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $254,250 to New York University (NYU) from July 1, 2025 to June 30, 2027. The funding supports research to understand how pathogenic alphaviruses, such as chikungunya virus, infect and spread through human microvascular endothelial cells. The research aims to identify viral and host factors that restrict alphavirus...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $155,454 to Washington University to conduct research on the molecular basis of receptor interactions for Venezuelan Equine Encephalitis Virus (VEEV). The key objectives are to identify alternative entry receptors for VEEV beyond the recently discovered primary receptor LDLRAD3, and to improve the therapeutic potential...
This Project Grant award of $734,184 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to elucidate the mechanisms of parainfluenza virus genome replication. The primary awardee, Trustees of Boston University, will conduct structure-guided analysis of the viral polymerase complex to understand how it regulates the balance between transcription and replication. The team will also investigate how viral...

HOST FACTOR CONTRIBUTION TO POSITIVE-STRAND RNA VIRUS INDUCED MEMBRANE REORGANIZATION - POSITIVE-SENSE SINGLE-STRAND RNA VIRUSES [(+)RNA VIRUSES] ARE RESPONSIBLE FOR A SIGNIFICANT PORTION OF HUMAN INFECTIONS AND REPRESENT A HIGH RISK FOR NEW AND EMERGING HUMAN DISEASES. THIS GROUP OF VIRUSES INCLUDES FLAVIVIRUSES SUCH AS DENGUE VIRUS (DENV), ZIKA VIRUS (ZIKV), AND WEST NILE VIRUS (WNV), WHICH ARE COLLECTIVELY RESPONSIBLE FOR >400 MILLION HUMAN INFECTIONS EACH YEAR. CHANGES IN HUMAN POPULATION DISTRIBUTION AND CLIMATE CHANGE THAT DRIVE MOVEMENT OF INSECT POPULATIONS THAT MEDIATE SPREAD OF FLAVIVIRUSES INTO NEW ENVIRONMENTS INCREASE THE RISK OF WIDESPREAD INFECTIONS IN NAIVE POPULATIONS. THIS RISK IS EXEMPLIFIED BY THE 2016 OUTBREAK OF ZIKA VIRUS IN SOUTH AMERICA AND IS ENHANCED BY THE CURRENT LACK OF EFFECTIVE VACCINES OR ANTIVIRALS. STUDIES AIMED AT DETERMINING THE MECHANISMS OF VIRUS INFECTION AND INTERACTIONS BETWEEN VIRUSES AND HOST CELLS ARE VITAL TO UNDERSTANDING AND CONTROLLING THESE PATHOGENS. THE OBJECTIVES OF THIS STUDY ARE TO INTERROGATE THE MECHANISMS BY WHICH FLAVIVIRUSES UTILIZE HOST PROTEIN NETWORKS THAT FACILITATE VIRAL REPLICATION AND TO INVESTIGATE METHODS TO DISRUPT THESE PROCESSES. ALL STUDIED (+)RNA VIRUSES REPLICATE IN HOST MEMBRANES WITH THE MAJORITY REQUIRING THE ER FOR THE FORMATION OF THEIR VIRAL REPLICATION ORGANELLES (VROS) THAT HAVE A HIGH LEVEL OF MORPHOLOGICAL CONSERVATION BETWEEN DISTANTLY RELATED (+)RNA VIRUS SPECIES. DESPITE WIDESPREAD INFECTION, RELATIVELY LITTLE IS KNOWN ABOUT THE SPECIFIC CONTRIBUTION OF HOST PROTEINS TO THE FORMATION OR STRUCTURE OF (+)RNA VIRUS VROS. OUR PRELIMINARY EXPERIMENTS HAVE IDENTIFIED A NETWORK OF HOST MEMBRANE FACTORS THAT ARE CRITICAL TO DENV AND ZIKV REPLICATION, LIKELY HAVING A ROLE IN THE FORMATION OF VROS. IN OUR FIRST AIM, WE WILL DEFINE THE ROLE OF THESE HOST MEMBRANE PROTEINS IN THE FORMATION OF VROS FOR TWO CLOSELY RELATED FLAVIVIRUSES, DENV AND ZIKV. TO DETERMINE IF THESE HOST PROTEINS ARE DIRECTLY INVOLVED IN VRO BIOGENESIS, WE WILL EMPLOY UNIQUE VIRUS EXPRESSION AND INFECTION SYSTEMS, WHICH ALLOW PRECISE EVALUATION OF EACH STEP IN THE VIRUS REPLICATION CYCLE, IN COMBINATION WITH INTEGRATED MICROSCOPY AND BIOCHEMICAL APPROACHES. WE WILL ALSO EXPAND OUR ANALYSIS TO DETERMINE IF THE IDENTIFIED HOST FACTORS HAVE COMMON FUNCTIONS FOR OTHER (+)RNA VIRUSES. IN OUR SECOND AIM, WE WILL USE GENE MANIPULATION AND MUTAGENESIS TO MECHANISTICALLY INTERROGATE THE FUNCTION OF SPECIFIC HOST MEMBRANE FACTORS IN VIRUS REPLICATION AND VRO FORMATION. THIS WORK WILL SIGNIFICANTLY ADVANCE UNDERSTANDING OF THE MECHANISMS UNDERPINNING FLAVIVIRUS MANIPULATION OF ER MEMBRANES, FURNISHING NOVEL INSIGHTS INTO FUNDAMENTAL VIRAL PROCESSES LIKELY TO BE SHARED BY A BROAD RANGE OF (+)RNA VIRUSES.

Posted 6/11/24, 12:00 AM